Advertisement

Topics

Celldex therapeutics Company Profile

20:56 EDT 24th September 2018 | BioPortfolio

Celldex is a biotechnology company focused on the discovery, development and commercialization of novel immunotherapeutics including human monoclonal antibodies for the treatment of cancer, infectious diseases, and immune system disorders. We are advancing a pipeline of clinical and pre-clinical product candidates.

Our proprietary core technology utilizes human monoclonal antibodies to directly target and deliver antigen for optimal processing to antigen presenting cells (APCs) and, in particular, to dendritic cells. Because these cells are critical for initiating the immune system's disease-fighting mechanisms, we believe product candidates using our APC Targeting Technology™ will create more potent immune responses to active immunization than standard immunotherapy strategies.

Location

222 Cameron Drive Suite 400
Phillipsburg
New Jersey
08865
United States of America

Contact

Phone: 908 454-7120
Fax: 908 454-1911
Email: information@celldextherapeutics.com


News Articles [756 Associated News Articles listed on BioPortfolio]

Celldex Therapeutics, Inc. Strategy, SWOT and Corporate Finance Report [Report Updated: 20062018] Prices from USD $175

Celldex Therapeutics, Inc. Strategy, SWOT and Corporate Finance ReportSummaryCelldex Therapeutics, Inc. Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and inf...

Celldex Therapeutics: Immunonkologie: Interessantes Biotech-Bottom-Play mit großem Upside-Potential nach Restrukturierung

Celldex Therapeutics (WKN: A0RA0S / ISIN: US15117B1035 / NASDAQ:CLDX) ist eine Biotech-Schmiede aus den USA mit einer vergleichsweise großen Pipeline und Fokus auf Immunonkologie. Der Aktienkurs ha.....

Celldex’ admission of defeat sends shares spiraling down

Shares in US biotech Celldex Therapeutics closed 65% down on Monday at $0.76 after the company announced…

Celldex cuts workforce by 20% after cancer drug trial failure

Targeted therapeutics company Celldex has announced it is reducing its employee numbers by 20% after a cancer drug failed to...Read More... The post Celldex cuts workforce by 20% after cancer drug tri...

Celldex Presents Data From Phase 1/2 Study Of Varlilumab And Opdivo

WASHINGTON (dpa-AFX) - Celldex Therapeutics, Inc. (CLDX) presented two programs at the 2018 American Society of Clinical Oncology Annual Meeting in Chicago. Data from the Phase 1/2 study of Cellde...

Celldex Therapeutics, Inc. Mergers Acquisitions MA, Partnerships Alliances and Investment Report [Report Updated: 26062018] Prices from USD $350

Celldex Therapeutics, Inc. Mergers Acquisitions MA, Partnerships Alliances and Investment ReportSummaryMarketline's Celldex Therapeutics, Inc. Mergers Acquisitions MA, Partnerships Alliances and ...

Stock Dives as Celldex Cuts 20% of Staff After Phase II Breast Cancer Failure

On April 16, Celldex Therapeutics reported that its Phase IIb trial of glembatumumab vedotin (glemba) failed in a trial of metastatic triple-negative breast cancer. Now the company has filed with the ...

Celldex Therapeutics Salvage Value

PubMed Articles [434 Associated PubMed Articles listed on BioPortfolio]

RNA Therapeutics (Almost) Comes of Age: Targeting, Delivery and Endosomal Escape.

Recent developments in intracellular protein delivery.

Protein therapeutics based on transcription factors, gene editing enzymes, signaling proteins and protein antigens, have the potential to provide cures for a wide number of untreatable diseases, but c...

RNA-targeted therapeutics for lipid disorders.

To summarize recent developments in the field of RNA-directed therapeutics targeting lipid disorders that are not effectively managed.

A Review of Therapeutics in Clinical Development for Respiratory Syncytial Virus and Influenza in Children.

Respiratory syncytial virus (RSV) and influenza are important viral pathogens worldwide. Children, in particular, bear considerable burdens of morbidity and mortality associated with these viruses. Th...

Pharmacokinetic Analysis of Intraocular Penetration of Latanoprost Solutions with Different Preservatives in Human Eyes.

Clinical Trials [155 Associated Clinical Trials listed on BioPortfolio]

A Study of CDX-1307, in Patients With Incurable Breast, Colorectal, Pancreatic, Ovarian or Bladder Cancer (CDX 1307-01)

This research study is for individuals who have advanced breast, colon, pancreatic, ovarian or bladder cancer. Celldex Therapeutics, Inc. is testing a form of immune therapy (vaccine) to s...

Phase I Study of CDX-1307, hCG-B Vaccine, for Patients With Incurable, Locally Advanced or Metastatic Breast, Colorectal, Pancreatic, Bladder or Ovarian Cancer

This research study is for individuals who have advanced breast, colon, pancreatic, ovarian or bladder cancer. Celldex Therapeutics, Inc. is testing a form of immune therapy (vaccine) to s...

Impact of Ibis on Patients With Advanced COPD

The purpose of this research is to determine if Ibis™, a digital therapeutics solution developed by Senscio Systems, reduces the emergency room visits and hospitalizations of patients wi...

HDL Acute Lipid Optimization in Homozygous Familial Hypercholesterolemia

Assess the effect on coronary atheroma of serial infusions of autologous selectively delipidated HDL/preβ enriched plasma following use of HDL Therapeutics PDS-2™ System

Ontogenesis of the P-Glycoprotein in Human Lymphocytes Influence of HIV and Antiretroviral Therapeutics

The P-glycoprotein (P-gp) is a membranous transporter that modulates the intracellular concentrations of many drugs and plays thus a major role in the efficacy of the therapeutics that act...

Companies [1259 Associated Companies listed on BioPortfolio]

Celldex Therapeutics Ltd

Celldex intends to grow the Company through a balanced combination of (a) internal development of product candidates, (b) continued in-licensing of synergistic technologies and adjuvant products, and ...

Celldex Therapeutics, Inc.

Celldex Therapeutics is the first antibody-based combination immunotherapy company. Celldex has a pipeline of drug candidates in development for the treatment of cancer and other ...

Celldex therapeutics

Celldex is a biotechnology company focused on the discovery, development and commercialization of novel immunotherapeutics including human monoclonal antibodies for the treatment of cancer, infectious...

Seattle Genetics, Inc.

Seattle Genetics is a clinical-stage biotechnology company focused on the development and commercialization of monoclonal antibody-based therapies for the treatment of cancer and ...

Aeris Therapeutics

Aeris Therapeutics is an emerging medical therapeutics company specializing in the development and commercialization of novel treatments for patients with emphysema and other adva...

More Information about "Celldex therapeutics" on BioPortfolio

We have published hundreds of Celldex therapeutics news stories on BioPortfolio along with dozens of Celldex therapeutics Clinical Trials and PubMed Articles about Celldex therapeutics for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Celldex therapeutics Companies in our database. You can also find out about relevant Celldex therapeutics Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Biotechnology
Antibodies Antisense Assays Biochips Bioinformatics Biological Therapy Biomarkers Biomaterials Bioscience Cell Culture Cloning Cytokine Diagnostics Dna Extraction Dna Sequencing Dna Transform...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Cancer Disease
Cancer is not just one disease but many diseases. There are more than 100 different types of cancer. Most cancers are named for the organ or type of cell in which they start - for example, cancer that begins in the colon is called colon cancer; cancer th...


Corporate Database Quicklinks



Searches Linking to this Company Record